POLYPEPTIDES SELECTIVE FOR ALPHA.V.BETA.3 INTEGRIN CONJUGATED WITH A VARIANT OF HUMAN SERUM ALBUMIN (HSA) AND PHARMACEUTICAL USES THEREOF
- 专利权人:
- NATIONAL TAIWAN UNIVERSITY
- 发明人:
- FU, WEN-MEI,CHUANG, WOEI-JER
- 申请号：
- NZ59758010
- 公开号：
- NZ597580A
- 申请日:
- 2010.07.19
- 申请国别(地区):
- NZ
- 年份:
- 2013
- 代理人:
- 摘要：
- 597580 Discloses is a polypeptide comprising a variant of human serum albumin (HSA) with a C34S or C34A mutation which is bound to SEQ ID NO: 1 as defined herein. SEQ ID NO: 1GKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIARLDDLDDRCTGQSADCPRYH
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- MUTANT SOLUBLE D'INTEGRINE .ALPHA.
- CXCL-13 ANTAGONISTS AND TNF-ALPHA ANTAGONISTS FOR USE IN A COMBINATION THERAPY
- As a delta964964alphaalpha [alpha 964964a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a p a a a a a a a a a a a a a a a a96a a a a a a a a a a a a a a a a a a a a a a p a a a a a a a a a a a a a a a a a a a a a a a a a a p a a a a a a a a a a a a a a a a a p a a a a a a a a a a a a a a a a a a CFTR
- The factors for prevention and treatment include the variation of delta alpha, alpha, RyR and alpha.
- The factors for prevention and treatment include the variation of delta alpha, alpha, RyR and alpha.
